Sign in
Taking peoplePhase 3

Colchicine compared with placebo for moderate aortic valve stenosis

Tests whether colchicine slows moderate aortic valve stenosis, compared with placebo.

Key facts

Who runs it
Stichting Radboud universitair medisch centrum
Where
Netherlands2 sites in 1 countryChoose a country to see its sites
Registry title
Colchicine and Inflammation in Aortic Stenosis (CHIANTI) trial
Status
Recruiting
Phase
Phase 3
People taking part
150 people, planned
Started
6 Dec 2024
Planned end
22 Dec 2025
Type of study
Interventional
Record updated
3 June 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people with moderate narrowing of the aortic heart valve (aortic valve stenosis) who have no symptoms. It compares colchicine with a placebo (dummy pill).

Age
50 to 80 years (people under 50 or over 80 cannot join)
Sex
All sexes
Disease stage
Moderate aortic valve stenosis without symptoms, seen on a heart ultrasound (echocardiography) from the last 6 months.
Earlier treatment
People cannot join if they use CYP3A4 or P-glycoprotein inhibitors (e.g. verapamil), bisphosphonate or denosumab. Long-term use of immunosuppressants or anti-inflammatory drugs, including colchicine and NSAID's, also rules people out. Acetylsalicylic acid is allowed.

Main reasons for not taking part

  • Heavily calcified aortic valve (grade 4), bicuspid or rheumatic aortic valve, or valve disease from past chest radiation
  • Aortic valve replacement planned in the next six months, or life expectancy under 2 years
  • Severe mitral valve stenosis (MVA < 1cm2), severe mitral or aortic valve leakage, or LVEF < 35%
  • Pacemaker or internal cardiac defibrillator, active or chronic liver disease, or eGFR <30 ml/min/1.73 m2
  • Long-term stomach or bowel complaints, or able to become pregnant without using contraception

The registry criteria, word for word

Show all 19 criteriaShow less

Who can take part

  • Asymptomatic moderate aortic valve stenosis on recent (<6 months) echocardiography (based on aortic valve peak velocity, aortic valve mean pressure gradient, aortic valve area). The severity of AS will be quantified according to current EACVI / ASE guidelines

Who cannot take part

  • Use of CYP3A4 (e.g. verapamil) or P-glycoprotein inhibitors
  • Chronic use of immunosuppressants or anti-inflammatory drugs including colchicine and NSAID's (excl. acetylsalicylic acid)
  • Active or chronic liver disease
  • The presence of a pacemaker or internal cardiac defibrillator
  • Rheumatic aortic valve disease
  • Valvular disease due to history of chest radiation
  • Left ventricular dysfunction (LVEF < 35%)
  • Renal impairment (eGFR <30 ml/min/1.73 m2)
  • Patients aged <50 and >80 years
  • Life expectancy <2 years
  • Heavily calcified aortic valve on echocardiography (defined as grade 4 calcification: extensive thickening/calcification of all cusps as described in the articles by Rosenhek et al.)
  • Pre-existing chronic gastro-intestinal complaints which may obscure signs of colchicine intolerance
  • Child-bearing potential without the use of contraception
  • Use of bisphosphonate or denosumab
  • A planned aortic valve replacement in the next six months
  • Severe mitral valve stenosis (MVA < 1cm2)
  • Severe mitral or aortic valve regurgitation
  • Bicuspid aortic valve

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To study the effect of colchicine treatment versus placebo on the progression of aortic valve stenosis in patients with moderate aortic valve stenosis.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Official title
Does Colchicine Reduce Progression of Aortic Valve Stenosis? Colchicine and Inflammation in Aortic Stenosis (CHIANTI): A placebo-controlled, double-blind, multicenter randomized trial.
Plain-language title
Colchicine compared with placebo for moderate aortic valve stenosisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
3 June 2025